Can-Fite: Reports Progress in the Development of Piclidenoso

Can-Fite: Reports Progress in the Development of Piclidenoson for Osteoarthritis in Pets Through its Partner Vetbiolix




●


... | August 17, 2022

Related Keywords

United States , France , Israel , American , Fite Biopharma , Motti Farbstein , Exchange Commission , Development Of Piclidenoson , Fite Biopharma Ltd , Drug Administration , Reports Progress , Pets Through , Orphan Drug Designation , Fast Track Designation , Can Fite Biopharma Ltd Stock Exchange , News , Information , Press Release , Reports , Progress , N , The , Development , F , Iclidenoson , Or , Osteoarthritis , Jets , Through , Its , Artner Canf Il0010944739 ,